64 related articles for article (PubMed ID: 17419272)
1. Predictors of systemic chemotherapy contraindication in pancreatic cancer patients with distant metastasis.
Zhang Y; Dang C; Ma Q; Chen W; Nagata K
Hepatogastroenterology; 2007; 54(73):254-9. PubMed ID: 17419272
[TBL] [Abstract][Full Text] [Related]
2. Predictive factors for tumor response to chemotherapy in patients with pancreatic cancer.
Fujishiro M; Okada S; Ueno H; Okusaka T; Ikeda M; Watanabe H; Tanaka N
Hepatogastroenterology; 2000; 47(36):1744-6. PubMed ID: 11149046
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapy.
Saisho T; Okusaka T; Ueno H; Morizane C; Okada S
Hepatogastroenterology; 2005; 52(66):1654-8. PubMed ID: 16334750
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors and predictive model in patients with advanced biliary tract adenocarcinoma receiving first-line palliative chemotherapy.
Park I; Lee JL; Ryu MH; Kim TW; Sook Lee S; Hyun Park D; Soo Lee S; Wan Seo D; Koo Lee S; Kim MH
Cancer; 2009 Sep; 115(18):4148-55. PubMed ID: 19536892
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for survival of patients with advanced gastric cancer treated with cisplatin-based chemotherapy.
Kim JG; Ryoo BY; Park YH; Kim BS; Kim TY; Im YH; Kang YK
Cancer Chemother Pharmacol; 2008 Feb; 61(2):301-7. PubMed ID: 17429626
[TBL] [Abstract][Full Text] [Related]
6. FP therapy for controlling malignant ascites in advanced pancreatic cancer patients.
Yonemori K; Okusaka T; Ueno H; Morizane C; Takesako Y; Ikeda M
Hepatogastroenterology; 2007 Dec; 54(80):2383-6. PubMed ID: 18265670
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in nonresectable pancreatic adenocarcinoma: a rationale to design therapeutic trials.
Cubiella J; Castells A; Fondevila C; Sans M; Sabater L; Navarro S; Fernández-Cruz L
Am J Gastroenterol; 1999 May; 94(5):1271-8. PubMed ID: 10235206
[TBL] [Abstract][Full Text] [Related]
8. Survival rate of pancreatic cancer in elderly patients.
Wang P; Meng ZQ; Chen Z; Lin JH; Zhou ZH; Chen H; Wang K; Shen YH; Zhu ZF; Zhao GF; Fu H; Liu LM
Hepatogastroenterology; 2008; 55(82-83):681-6. PubMed ID: 18613433
[TBL] [Abstract][Full Text] [Related]
9. Predicting factors for survival of patients with unresectable pancreatic cancer: a management guideline.
Fujino Y; Suzuki Y; Ajiki T; Tanioka Y; Ku Y; Kuroda Y
Hepatogastroenterology; 2003; 50(49):250-3. PubMed ID: 12630033
[TBL] [Abstract][Full Text] [Related]
10. Review of adjuvant radiochemotherapy for resected pancreatic cancer and results from Mayo Clinic for the 5th JUCTS symposium.
Miller RC; Iott MJ; Corsini MM
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):364-8. PubMed ID: 19735864
[TBL] [Abstract][Full Text] [Related]
11. [Which is the best monitoring study (tumor marker, computed tomography or 18F-fluoro-2-deoxy-D-glucose positron emission tomography) to evaluate efficacy of chemotherapy on unresectable pancreatic cancer ?].
Kobayashi N; Fujita K; Fujisawa T; Takahashi H; Yoneda M; Abe Y; Inamori M; Kirikoshi H; Kubota K; Saito S; Nakajima A
Gan To Kagaku Ryoho; 2008 Jan; 35(1):65-70. PubMed ID: 18195530
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for long-term survival in patients with locally invasive pancreatic cancer.
Tani M; Kawai M; Terasawa H; Ina S; Hirono S; Shimamoto T; Miyazawa M; Uchiyama K; Yamaue H
J Hepatobiliary Pancreat Surg; 2007; 14(6):545-50. PubMed ID: 18040618
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis.
Papadoniou N; Kosmas C; Gennatas K; Polyzos A; Mouratidou D; Skopelitis E; Tzivras M; Sougioultzis S; Papastratis G; Karatzas G; Papalambros E; Tsavaris N
Anticancer Res; 2008; 28(1B):543-9. PubMed ID: 18383900
[TBL] [Abstract][Full Text] [Related]
14. Intra-arterial infusion chemotherapy with 5-fluorouracil and cisplatin in advanced pancreatic cancer: a feasibility study.
Sasada T; Denno R; Tanaka T; Kanai M; Mizukami Y; Kohno S; Takabayashi A
Am J Clin Oncol; 2008 Feb; 31(1):71-8. PubMed ID: 18376231
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic head carcinoma: clinical analysis of 189 cases.
Hua YP; Liang LJ; Peng BG; Li SQ; Huang JF
Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):79-84. PubMed ID: 19208521
[TBL] [Abstract][Full Text] [Related]
16. Preoperative serum CA19-9 and dissected peripancreatic tissue margin as determiners of long-term survival in pancreatic cancer.
Waraya M; Yamashita K; Katagiri H; Ishii K; Takahashi Y; Furuta K; Watanabe M
Ann Surg Oncol; 2009 May; 16(5):1231-40. PubMed ID: 19263172
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in patients treated with taxane-based chemotherapy for recurrent or metastatic endometrial cancer: proposal for a new prognostic model.
Mountzios G; Bamias A; Voulgaris Z; Rodolakis A; Vlahos G; Gourgoulis G; Papaiakovou EE; Giannopoulos A
Gynecol Oncol; 2008 Jan; 108(1):130-5. PubMed ID: 17988722
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in survival of colorectal cancer patients after surgery.
Mehrkhani F; Nasiri S; Donboli K; Meysamie A; Hedayat A
Colorectal Dis; 2009 Feb; 11(2):157-61. PubMed ID: 18462239
[TBL] [Abstract][Full Text] [Related]
19. Neoplastic meningitis-related prognostic significance of the Karnofsky performance status.
Chamberlain MC; Johnston SK; Glantz MJ
Arch Neurol; 2009 Jan; 66(1):74-8. PubMed ID: 19139302
[TBL] [Abstract][Full Text] [Related]
20. Factors influencing survival after bypass procedures in patients with advanced pancreatic adenocarcinomas.
Müller MW; Friess H; Köninger J; Martin D; Wente MN; Hinz U; Ceyhan GO; Blaha P; Kleeff J; Büchler MW
Am J Surg; 2008 Feb; 195(2):221-8. PubMed ID: 18154768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
